Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: A Systematic Review and Meta-analysis
Fabiane B. Klem,Fabiane B. Klem,Akhilesh Wadhwa,Larry J. Prokop,Wendy Sundt,Gianrico Farrugia,Michael Camilleri,Siddharth Singh,Madhusudan Grover +8 more
Reads0
Chats0
TLDR
In a systematic review and meta-analysis, it is found >10% of patients with infectious enteritis develop IBS later; risk of IBS was 4-fold higher than in individuals who did not have infectiousEnteritis, although there was heterogeneity among studies analyzed.About:
This article is published in Gastroenterology.The article was published on 2017-04-01 and is currently open access. It has received 286 citations till now. The article focuses on the topics: Enteritis & Risk factor.read more
Citations
More filters
Journal ArticleDOI
ACG Clinical Guideline: Management of Irritable Bowel Syndrome.
Brian E. Lacy,Mark Pimentel,Darren M. Brenner,William D. Chey,Laurie Keefer,Millie D. Long,Baha Moshiree +6 more
TL;DR: This first-ever American College of Gastroenterology clinical guideline for the management of IBS recommends that a positive diagnostic strategy as compared to a diagnostic strategy of exclusion be used to improve time to initiating appropriate therapy and recommends gut-directed psychotherapy to treat global IBS symptoms.
Journal ArticleDOI
Global burden of irritable bowel syndrome: trends, predictions and risk factors
TL;DR: An overview of the global burden of irritable bowel syndrome is provided in a global context, to discuss future implications for the care of people with IBS worldwide, and to identify key areas for further research.
Journal ArticleDOI
The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy
TL;DR: The pathophysiology of IBS and the role of gut microbiota in relation to IBS is summarized and future directions in IBS therapy research are highlighted, including identification of new molecular targets, application of 3-D gut model, gut-on-a-chip and personalized therapy.
Journal ArticleDOI
The role of psychological and biological factors in postinfective gut dysfunction
Kok Ann Gwee,Y. L. Leong,C. Graham,M.W. McKendrick,Stephen M. Collins,Stephen J Walters,J. E. Greenwood,Nicholas W. Read +7 more
TL;DR: Psychological factors most clearly predict the development of IBS symptoms after gastroenteritis but biological mechanisms also contribute towards the expression of symptoms.
Journal ArticleDOI
Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic.
Joane Matta,Emmanuel Wiernik,Olivier Robineau,Olivier Robineau,Fabrice Carrat,Mathilde Touvier,Gianluca Severi,Gianluca Severi,Xavier de Lamballerie,Hélène Blanché,Jean-François Deleuze,Clément Gouraud,Nicolas Hoertel,Brigitte Ranque,Marcel Goldberg,Marie Zins,Cédric Lemogne +16 more
TL;DR: In this article, the authors examined the associations of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms (e.g., fatigue, breathlessness, or impaired attention) in the general population during the COVID19 pandemic.
References
More filters
Journal ArticleDOI
Measuring inconsistency in meta-analyses
TL;DR: A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.
Journal ArticleDOI
Bias in meta-analysis detected by a simple, graphical test
TL;DR: Funnel plots, plots of the trials' effect estimates against sample size, are skewed and asymmetrical in the presence of publication bias and other biases Funnel plot asymmetry, measured by regression analysis, predicts discordance of results when meta-analyses are compared with single large trials.
Journal ArticleDOI
Meta-Analysis in Clinical Trials*
TL;DR: This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.
The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
TL;DR: The Newcastle-Ottawa Scale (NOS) as discussed by the authors was developed to assess the quality of nonrandomised studies with its design, content and ease of use directed to the task of incorporating the quality assessments in the interpretation of meta-analytic results.
Journal ArticleDOI
AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews.
Beverley Shea,Candyce Hamel,George A. Wells,Lex M. Bouter,Elizabeth Kristjansson,Jeremy M. Grimshaw,David Henry,Maarten Boers +7 more
TL;DR: AMSTAR has good agreement, reliability, construct validity, and feasibility, and these findings need confirmation by a broader range of assessors and a more diverse range of reviews.